Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Melanotan-2

MT-II, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2

Quick Stats
Studies 3
Trials 100
Score 2
2020 pubmed 3 citations

CAPS2 deficiency induces proopiomelanocortin accumulation in pituitary and affects food intake behavior in mice.

Fujima. Shuhei S; Amemiya. Natsuki N; Arima. Tomoki T; Sano. Yoshitake Y; Furuichi. Teiichi T

Key Findings

  • CAPS2 is present in POMC‑producing neurons and helps release alpha‑MSH.
  • Mice without CAPS2 have higher levels of POMC protein in the pituitary, suggesting a secretion problem.
  • A low dose of melanotan‑2 reduces food intake per body weight in CAPS2‑deficient mice but not in wild‑type mice.

Practical Outcomes

  • For biohackers, this study hints that melanotan‑2 might only suppress appetite under specific physiological conditions (e.g., impaired CAPS2 function). It doesn’t support using MT2 as a universal appetite suppressant in healthy people, but it adds a piece to the puzzle of how alpha‑MSH pathways can be modulated.

Summary

In mice that lack the protein CAPS2, the precursor to the appetite‑controlling hormone alpha‑MSH builds up in the pituitary, and giving them a tiny dose of melanotan‑2 (an alpha‑MSH receptor agonist) makes them eat less relative to their body weight. Normal mice don’t show this effect.

Abstract

Proopiomelanocortin (POMC) is a neuropeptide precursor produced in the anterior and intermediate pituitary lobes, the hypothalamic arcuate nucleus (ARC), and solitary tract nucleus. Alpha-melanocyte-stimulating hormone (&#x3b1;-MSH) is a cell type specific POMC derivative that is essential for regulating feeding, and energy homeostasis. However, the molecular mechanism underlying POMC/&#x3b1;-MSH secretion remains unclear. Ca<sup>2+</sup>-dependent activator protein for secretion 2 (CAPS2) is a regulatory protein involved in the exocytosis of dense-core vesicles containing neuropeptides. We previously reported CAPS2 localization in the intermediate pituitary lobe and reduced body weights in Caps2-knockout (Caps2-KO) mice, compared to control mice. Here, we aimed to investigate CAPS2 expression in POMC-expressing neurons and the effects of CAPS2 deficiency on the secretion of POMC-related peptides and feeding behavior phenotype. CAPS2 was localized in the POMC-expressing neurons of the intermediate pituitary lobe, hypothalamic ARC, and the paraventricular nucleus, which is innervated by hypothalamic neurons. POMC protein levels in the intermediate pituitary lobe of Caps2-KO mice were significantly higher than that in the control mice, suggesting a possible accumulation of POMC-derived peptides in the intermediate pituitary lobe of Caps2-KO mice. Moreover, administration of low-dose melanotan-2, an &#x3b1;-MSH receptor (MC4R) agonist, decreased food intake per body weight in Caps2-KO mice; no such effect was observed in the wildtype mice. Collectively, these results suggest that CAPS2 is involved in regulating the secretion of POMC-derived peptides, including &#x3b1;-MSH, is partially associated with feeding, and affects energy metabolism.

Study Information

Provider

pubmed

Year

2020

Date

2020-09-03T00:00:00.000Z

DOI

10.1016/j.neulet.2020.135335

Citations

3

References

26